Dan-qi Wang
Wuhan, 430071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 23, 2025
Gadd45a knockout alleviates cisplatin-induced hearing loss by inhibiting CXCL family protein expression.
Journal: Military Medical Research
Published: September 18, 2025
Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021.
Journal: Military Medical Research
Published: June 07, 2024
Downregulation of N6-methyladenosine-modified LINC00641 promotes EMT, but provides a ferroptotic vulnerability in lung cancer.
Journal: Cell death & disease
Published: November 17, 2022
A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1.
Journal: Cell death & disease
Published: July 19, 2022
Can Routine Blood and Urine Parameters Reveal Clues to Detect Bladder Cancer? A Case-Control Study.
Journal: Frontiers in oncology
Published: October 18, 2021
Knowledge of and Compliance With Guidelines in the Management of Non-Muscle-Invasive Bladder Cancer: A Survey of Chinese Urologists.
Journal: Frontiers in oncology
Published: July 03, 2021
Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019.
Journal: Military Medical Research
Published: June 30, 2021
Determinants of successful guideline implementation: a national cross-sectional survey.
Journal: BMC medical informatics and decision making
Published: June 24, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026